Cargando…
The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia
BACKGROUND: The clinical predictors of aromatase inhibitor-related arthralgia (AIA), a drug-related adverse reaction of aromatase inhibitors (AIs), remain unclear. METHODS: AIA was prospectively surveyed every 4 months in 328 postmenopausal breast cancer patients administered a non-steroidal AI (ana...
Autores principales: | Kanematsu, Miyuki, Morimoto, Masami, Honda, Junko, Nagao, Taeko, Nakagawa, Misako, Takahashi, Masako, Tangoku, Akira, Sasa, Mitsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198721/ https://www.ncbi.nlm.nih.gov/pubmed/21985669 http://dx.doi.org/10.1186/1471-2407-11-436 |
Ejemplares similares
-
Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
por: Honda, Junko, et al.
Publicado: (2011) -
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
por: Nagao, Taeko, et al.
Publicado: (2009) -
A case of matrix-producing carcinoma of the breast
por: Hirose, Toshiyuki, et al.
Publicado: (2008) -
Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010) -
Management of arthralgias associated with aromatase inhibitor therapy
por: Thorne, C.
Publicado: (2007)